Author: MyHairline Editorial Team Editorial review: MyHairline medical content review. Named clinician reviewer pending verified reviewer relationship and crawlable bio. Last updated: May 2026
Educational use only. This article is not medical advice and does not endorse any specific platform. Finasteride, oral minoxidil, and other prescription medications offered through telehealth platforms require licensed clinician evaluation and prescription. The Myhairline.ai analyzer is an educational classification tool and does not prescribe.
Last October, a 31-year-old marketing manager named Derek in Austin told me he'd spent four hours on a Sunday toggling between the Keeps and Hims checkout pages, both tabs open side by side, trying to figure out if there was actually a meaningful difference between the two. "I kept looking for the catch," he said. "Like one of them had to be better, right? They're charging me $40 a month. For what?" He ended up flipping a coin. Landed on Hims. Six months later, his hair looked about the same as it would have on Keeps, because the drugs inside the boxes were identical.
That anecdote pretty much tells you everything you need to know. But the details matter, so let's get into them.
The Boring Truth About What You're Actually Buying
Both Keeps and Hims prescribe generic finasteride 1 mg and topical minoxidil 5 percent. Same molecules. Same FDA-registered generic manufacturers. If you took the pills out of their branded packaging and put them on a table, a pharmacist couldn't tell you which subscription they came from.
The real differences between these platforms have nothing to do with pharmacology. They're about price, consultation experience, ancillary products, customer service, and how easy it is to cancel. Think of it like choosing between two gas stations on opposite corners of the same intersection. The unleaded is the same. You're picking based on the coffee, the bathroom, and whether the pump takes Apple Pay.
This hub anchors the Comparisons & Decision-Making cluster on Myhairline.ai because that framework applies to almost every comparison in the hair-loss space: laser caps, PRP vs. microneedling, transplant clinics. The active ingredient matters more than the brand on the box, every single time.
Who Are These Companies?
Hims (Hims and Hers Health, NYSE: HIMS) launched in 2017, went public via SPAC in 2021, and sprawls across hair loss, sexual health, mental health, skincare, and weight management. The hair-loss lineup includes generic finasteride 1 mg, topical minoxidil 5 percent (solution and foam), compounded oral minoxidil, biotin gummies, shampoos, and a proprietary topical combo called the Hair Power Pack.
Keeps (Thirty Madison) launched in 2018 as part of a telehealth brand portfolio. It stays more narrowly focused on hair loss, offering generic finasteride 1 mg, topical minoxidil 5 percent (solution and foam), ketoconazole 1 percent shampoo, and a Thickening Shampoo.
The clinical workflow is functionally the same at both: asynchronous online intake with health history and photo upload, review by a contracted licensed clinician (usually a physician or nurse practitioner licensed in your state), prescription dispensed through a partner pharmacy, recurring shipment to your door.
What You'll Actually Pay
Pricing shifts with promotions, so verify these on each platform's current page. These are typical published rates as of early 2026.
Generic finasteride 1 mg (monthly subscription). Hims: roughly $22 to $28. Keeps: roughly $25 to $30.
Topical minoxidil 5 percent (monthly subscription). Hims: roughly $16 to $22. Keeps: roughly $15 to $25.
Finasteride + minoxidil bundle. Hims: roughly $40 to $50. Keeps: roughly $35 to $45.
Now, here's the thing. Generic finasteride 1 mg through a standard U.S. retail pharmacy with a GoodRx-style discount card runs about $8 to $15 per month. The telehealth premium covers the consultation, the shipping, the packaging, the customer support. It's a convenience fee. For a price-sensitive guy with an existing prescription, filling at a local pharmacy with a discount card is almost always cheaper, though you lose the auto-ship and the (minimal) clinician follow-up.
Over five years, that $15-to-$25 monthly premium adds up to $900 to $1,500 in extra spending. That's real money. Worth it for some people, genuinely not for others.
The Consultation Question
Both platforms rely on asynchronous, photo-based, questionnaire-driven consultations. The reviewing clinician is licensed but typically not a board-certified dermatologist, and the review is brief. For a straightforward case (otherwise healthy adult male, classic Norwood pattern, no confounding symptoms), this works fine.
Where this falls apart is when the case isn't straightforward.
Patchy loss needs in-person evaluation to rule out alopecia areata. Scarring patterns, eyebrow thinning, or porcelain-white scalp at the hairline need evaluation for frontal fibrosing alopecia and other scarring conditions. Rapid onset, scalp pain, scalp itch, or systemic symptoms need a real exam. Confounding factors like thyroid disorders, iron deficiency, or hormonal abnormalities need bloodwork, not a photo upload.
Both platforms include intake questions that screen for some of these red flags and will, in some cases, decline to prescribe and refer you to in-person care. How reliably they catch edge cases is hard to assess from the outside. The screening sensitivity is variable.
My genuinely opinionated take: if you have any doubt about your diagnosis, skip both platforms and see a dermatologist first. Optimizing your subscription choice before confirming your diagnosis is like comparison-shopping running shoes before you know if your ankle is broken.
The Adjunct Products: Where They Diverge
The core medications are identical. The extras are where personality differences show up.
Hims leans broader. The big differentiator is access to compounded oral minoxidil at low doses, increasingly used off-label by dermatologists for patients who can't tolerate the topical version. A 2021 review by Randolph and Tosti in the Journal of the American Academy of Dermatology summarized emerging evidence for this approach. Oral minoxidil carries somewhat more clinical complexity (blood pressure effects, fluid retention, potential for hypertrichosis) and demands careful prescribing.
Keeps leans narrower and hair-focused. Ketoconazole 1 percent shampoo is a standard offering. It has limited but genuine published support as an adjunct in androgenetic alopecia. Pierard-Franchimont et al. reported modest hair-shaft caliber improvements with twice-weekly use in a 1998 trial in Dermatology, with a few smaller follow-up studies since. The evidence base is a fraction of what exists for finasteride or minoxidil, but it's not nothing.
Both platforms sell proprietary supplements (biotin gummies, multivitamins). Unless you have a documented deficiency, the clinical benefit of these is slim. They do, however, reliably increase your monthly bill.
Cancellation and Customer Experience
Both operate recurring subscription models that auto-renew. Independent review sites (Trustpilot, Better Business Bureau) paint a similar picture for both: mixed, with the most frequent complaints about cancellation difficulty, billing errors, and inconsistent shipping. Neither platform distinguishes itself here.
A practical tip that applies to both: set a calendar reminder at the six-month mark. That's the published minimum time-to-effect for both finasteride (Kaufman et al., 1998, JAAD) and minoxidil (Olsen et al., 2002, JAAD). At six months, you can make a rational assessment of whether the medication is working for you and whether the subscription convenience justifies the premium over a pharmacy fill.
Read the cancellation terms before you sign up, not after you decide to leave.
How to Think About Any Hair-Loss Comparison
This same logic applies to every other head-to-head in the cluster, whether it's laser caps, procedures, or treatment modalities.
Confirm the diagnosis before you compare brands. Everything downstream of a wrong diagnosis is wasted money and time.
Find the active ingredient or core mechanism. Many branded products are commodity molecules in premium packaging. The clinical effect lives in the molecule.
Rank by evidence quality, not marketing polish. Finasteride, minoxidil, and surgical hair restoration sit at the top. PRP, microneedling, and low-level laser therapy have moderate support. Supplements and most cosmetic products have weak support. The brand comparison matters far less than the modality choice.
Calculate total cost over years, not months. Hair-loss therapy is a multi-year commitment. Five-year cost is more honest than the introductory monthly rate.
Match the consultation to the complexity. Uncomplicated androgenetic alopecia? Asynchronous telehealth is fine. Anything ambiguous? See a dermatologist in person.
Common Questions About Keeps vs. Hims
Is the medication actually different between platforms? No. Both dispense generic finasteride 1 mg and generic minoxidil 5 percent from FDA-registered generic manufacturers. The active pharmaceutical ingredient is identical.
Do I need a prescription for minoxidil? Topical minoxidil (2 percent and 5 percent solutions, 5 percent foam) is over-the-counter in the United States. Oral minoxidil and many compounded combinations require a prescription. Finasteride always requires a prescription.
Can I get a board-certified dermatologist consultation through telehealth? Yes. Several platforms offer it, though typically at higher price points and with longer scheduling timelines than asynchronous services. For complicated cases or unclear diagnoses, this is usually the right tradeoff.
What about side-effect monitoring on a subscription model? Both platforms include some clinician follow-up cadence. Practically, side-effect monitoring on asynchronous platforms is patient-driven. If you experience symptoms that might be medication-related, contact the platform's clinical team or your own clinician immediately rather than waiting for a scheduled check-in.
How do I compare laser caps fairly? Look for FDA 510(k) clearance (basic safety review, not full efficacy proof), published clinical trial data specific to the device model, total diode count and irradiance, treatment time per session and per week, warranty terms, and independent user reviews spanning twelve months or more. Marketing claims of "guaranteed regrowth" are red flags regardless of device.
Should I just go to a regular pharmacy instead? If you already have a prescription and you're comfortable managing refills yourself, yes, a retail pharmacy with a discount card is almost certainly cheaper. You lose the convenience of auto-ship and the (limited) asynchronous clinician access.
Does it matter which platform I pick? Honestly? Not much. The medication is the same. Pick the one with the pricing structure and cancellation policy you prefer, and remember that neither one is a substitute for a proper diagnosis.
Continue Reading Across the Comparisons & Decision-Making Cluster
This page is the cluster hub for Comparisons & Decision-Making on Myhairline.ai. The pillar overview lives at The Norwood Scale: Complete Guide. Supporting articles:
- Him Vs Keeps, alternate phrasing reference for the platform comparison.
- Theradome Vs Irestore, laser device comparison.
- Theradome Vs Capillus, laser device comparison.
- Irestore Vs Capillus, laser device comparison.
- Capillus Vs Irestore, alternate phrasing reference.
- Microneedling Vs Prp Hair Growth Effectiveness Comparison, procedure comparison.
- Diffuse Thinning Vs Male Pattern Baldness, diagnostic distinction that drives different treatment paths.
- Hair Transplant Vs Medication Vs Lifestyle, the three-modality treatment-strategy comparison.
- Tell Me About Hair Transplant Companies And Which Is Best: Complete Guide, the evaluation framework for clinic selection.
- The Norwood Scale: Complete Guide to Male Pattern Hair Loss Stages, the pillar.
Key References
Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology. 1998;39(4):578-589.
Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002;47(3):377-385.
Pierard-Franchimont C, De Doncker P, Cauwenbergh G, Pierard GE. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology. 1998;196(4):474-477.
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. Journal of the American Academy of Dermatology. 2021;84(3):737-746.
Beach RA, Wilkinson KA, Gumedze F, Khumalo NP. Aluminium chloride and minoxidil for treating hair loss: a systematic review. British Journal of Dermatology. 2015;172(1):116-127.
Gupta AK, Bamimore MA. Finasteride versus dutasteride for androgenetic alopecia: a systematic review. Journal of the American Academy of Dermatology. 2022;87(5):1149-1151.
Hamilton JB. Patterned loss of hair in man: types and incidence. Annals of the New York Academy of Sciences. 1951;53(3):708-728.
Norwood OT. Male pattern baldness: classification and incidence. Southern Medical Journal. 1975;68(11):1359-1365.